MAISLIN

Serial Number 75505723
606

Registration Progress

Application Filed
Jun 19, 1998
Under Examination
Aug 17, 1999
Approved for Publication
Apr 23, 1999
Published for Opposition
May 25, 1999
Registered

Trademark Image

MAISLIN

Basic Information

Serial Number
75505723
Filing Date
June 19, 1998
Published for Opposition
May 25, 1999
Abandonment Date
August 18, 2002
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 18, 2002
Classes
005

Rights Holder

Maitake Products, Inc.

03
Address
222 Bergan Turnpike
Ridgefield Park, NJ 07660

Ownership History

Maitake Products, Inc.

Original Applicant
03
Ridgefield Park, NJ

Maitake Products, Inc.

Owner at Publication
03
Ridgefield Park, NJ

Legal Representation

Attorney
KELLIE M ULRICH

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Mar 26, 2003 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 21, 2002 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 11, 2002 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 21, 2001 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 13, 2001 REIN O REINSTATED Loading...
Aug 13, 2001 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 10, 2001 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 30, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 15, 2001 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 29, 2000 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 8, 2000 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 6, 2000 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 9, 2000 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 17, 1999 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 25, 1999 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 23, 1999 NPUB O NOTICE OF PUBLICATION Loading...
Mar 10, 1999 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 24, 1999 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations made from mushrooms for the treatment of hypertension, hyperlipidemia, insulism, obesity, diabetes, chronic fatigue syndrome, hepatitis, cancer and HIV positive/AIDS in the form of tablets, capsules, suppositories and ample for injection use, and dietary, nutritional and food supplements made from mushrooms in the form of tablets, capsules, tincture, extract, powder and tea
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005